Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: An immunohistochemical study

British Journal of Urology

Volumn 81, Issue 6, 1998, Pages 862-869

  Osen, I ^a   Fossa S D ^a   Majak, B ^b   Rotterud R ^a   Berner, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b TELEMARK HOSPITAL   (Norway)

Author keywords

Ki 67; Muscle invasive bladder cancer; P21; P53; Prognostic factors

Indexed keywords

KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, TRANSITIONAL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0031865344     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00657.x     Document Type: Article

References (40)

1. Jacks T, Remington L, Williams BO et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4: 1-7
2. Rowan S, Ludwig RL, Haupt Y et al. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J 1996; 15: 827-38
3. Lowe SW. Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-9
4. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246: 629-34
5. Kastan MB. Zhan Q, el Deiry WS et al Amammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992: 71: 587-97
6. el Deiry WS, Harper JW, O'Connor PM et al. WAFl/CIPl is induced in p53-mediated Gl arrest and apoptosis. Cancer Res 1994: 54: 1169-74
7. el Deiry WS. Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25
8. Dulic V. Kaufmann WK. Wilson SJ et al. p53-dependent inhibition of cyclin-dependent kinase activities in human flbroblasts during radiation-induced Gl arrest. Cell 1994; 76: 1013-23
9. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391-5
10. Sheikh MS. Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA. Mechanisms of regulation of WAFl/Cipl gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 1994; 9: 3407-15
11. Lee AK, Wiley B, Loda M et al. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma. Mod Pathol 1992; 5: 61-7
12. Sarkis AS, Dalbagni G, Cordon Cardo C et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 1993; 85: 53-9
13. Serth J, Kuczyk MA, Bokemeyer C et al. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer 1995; 71: 201-5
14. Lipponen PK. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. M J Cancer 1993; 53: 365-70
15. Esrig D, Elmajian D, Groshen S et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994; 331: 1259-64
16. International Union Against Cancer (UICC). Urological Tumours. In Hermanek P, Sobin LH, eds, TNM Classification of Malignant Tumours. 4th ed. Springer-Verlag, 1987: 121-44
17. Mostofi FK. Introduction. In Mostofl FK, Sobin LH, Torloni H, eds, Histological Typing of Urinary Bladder Tumours. World Health Organization, 1973: 17
18. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am JClin Pathol 1981; 75: 734-8
19. Kraggerud SM, Dolven Jacobsen K, Berner A et al. A comparison of different modes for the detection of p53 protein accumulation. Path Res Pract 1997; in press
20. Cordon Cardo C, Dalbagni G, Saez GT et al. p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer 1994; 56: 347-53
21. Esrig D, Spruck CH 3rd, Nichols PW et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer Am J Pathol 1993; 143: 1389-97
22. Thor AD, Moore DH II, Edgerton SM et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992; 84: 845-55
23. Starzynska T, Bromley M. Ghosh A, Stern PL. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992; 66: 558-62
24. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992: 52:4828-31
25. Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 1992; 84: 883-7
26. Moch H, Sauter G, Mihatsch M], Gudat F. Epper R, Waldman FM. p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer. Hum Pathol 1994; 25: 1346-51
27. Gomyo Y, Ikeda M, Osaki M et al Expression of p21 (WAFl/Cipl/SDIl), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Am Cancer Soc 1997: 79: 2067-72
28. Braithwaite KL, Kilian Mellon J, Neal DE et al. Wafl expression in transitional cell carcinoma (TCC) of the bladder: inverse relationship to p53 accumulation and association with good prognosis. J Urol 1997; 157: 26
29. el Deiry WS, Tokino T, Waldman T et al Topological control of p21WAFl/CIPl expression in normal and neoplastic tissues. Cancer Res 1995; 55: 2910-9
30. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell 1993; 75: 805-16
31. Mameghan H, Fisher R. Invasive bladder cancer. Prognostic factors and results of radiotherapy with and without cystectomy. Br J Urol 1989; 63: 251-8
32. Pagano F, Bassi P, Galetti TP et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and métastases classification. J Urol 1991; 145:45-50
33. Kuczyk MA, Bokemeyer C, Serth J et al. p53 overexpression as a prognostic factor for advanced stage bladder cancer. Eur] Cancer 1995; 31A: 2243-7
34. Stein JP, Ginsberg DA, Grossfeld GD et al. The effect of p2jwAFi/opi expressjon anc[ tumor progression in bladder cancer. J Urol 1997; 157: 161
35. King ED. Matteson J, Jacobs SC. Kyprianou N. Incidence of apoptosis. cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol 1996; 155: 316-20
36. Nakano T, Oka K. Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer. Cancer 1993; 72: 2401-8
37. Kastan MB. Kuerbitz SJ. Control of Gl arrest after DNA damage. Environ Health Perspect 1993; 101: 55-8
38. Kuerbitz SJ, Plunkett BS. Walsh WV, Kastan MB. Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sä USA 1992; 89: 74915
39. Sarkis AS, Bajorin DF, Reuter VE et al. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC J Clin Oncol 1995; 13: 1384-90
40. Jahnson S, Risberg B, Karlsson MG, Westman G, Bergstrom R, Pedersen J. p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy. Eur Urol 1995: 28: 135-42